Mohammed Yusuf

Papers

Total Citations

H-Index

About

Dr. Mohammed Yusuf is a pioneering researcher at the forefront of nanomedicine and cancer therapeutics, whose work bridges the critical gap between nanotechnology and clinical oncology. His most-cited paper, "A Path of Novelty from Nanoparticles to Nanobots: Theragnostic Approach for Targeting Cancer Therapy" (2023), has garnered 6 citations and represents a visionary synthesis of diagnostic and therapeutic strategies. Dr. Yusuf’s major contribution lies in conceptualizing a seamless transition from passive nanoparticle delivery systems to active, intelligent nanobots capable of real-time imaging and targeted drug release—a paradigm shift in theragnostic approaches. By addressing the limitations of conventional cancer therapies, including poor specificity and systemic toxicity, his research offers a roadmap for personalized, minimally invasive treatments. This work underscores his commitment to translating fundamental nanoscience into practical oncological solutions, positioning him as a key voice in the fight against cancer. His innovative framework continues to inspire interdisciplinary collaborations, making him a vital figure for students and researchers exploring the future of precision medicine.